학술논문
438 - Determining the Safety and Efficacy of Prophylactic Defibrotide Administration in Children, Adolescents, and Young Adults with High-Risk Sickle Cell Disease (SCD) or Beta Thalassemia Major Following Myeloimmunoablative Conditioning (MAC) and Haploidentical Stem Cell Transplantation Utilizing CD34+ Selection and T-Cell (CD3) Addback (IND127812)
Document Type
Abstract
Author
Source
In Transplantation and Cellular Therapy March 2022 28(3) Supplement:S341-S341
Subject
Language
ISSN
2666-6367